Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

OPK - STRONG BUY $14.50 6-Mo Target

|Includes:OPKO Health, Inc. (OPK)

High conviction for OPK, $14.50 next high to be hit. Advancement on timing re: POS diagnostics; Expected high U.S. uptick for Prostate screen (vs. Europe's weaker than expected sales) and positive top line results for next drug all serious catalysts within 3-6 months. Story favorable to company to be published through Bloomberg/google/yahoo network shortly. Recent insider CEO buys too.

Stocks: OPK